Abstract
The population-level public health benefits of HIV pre-exposure prophylaxis (PrEP) in preventing HIV transmissions among gay, bisexual, and other men who have sex with men (hereafter referred to as MSM) have been shown by decreases in new HIV diagnoses in settings with high PrEP uptake, including where HIV testing and treatment are already high.1 In New South Wales, Australia, following the establishment of a large PrEP implementation study, new HIV diagnoses among MSM in the 12 months after PrEP roll-out decreased by 25·1%, and recent HIV diagnoses (ie, diagnoses among men who acquired HIV in the previous 12 months) decreased by 31·5%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
